LARIMAR THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number
LARIMAR THERAPEUTICS, INC. (LRMR) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number of 11.06 million shares as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber · last filed 2026-08-04
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number 11.06M shares.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number 10.58M shares.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number 8.61M shares.
- 2025-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number 8.58M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number |
|---|---|
| 2026-06-30 | 11.06M shares 10-Q · filed 2026-08-04 |
| 2026-03-31 | 10.58M shares 10-Q · filed 2026-05-14 |
| 2025-09-30 | 8.61M shares 10-Q · filed 2025-11-05 |
| 2025-06-30 | 8.58M shares 10-Q · filed 2025-08-14 |
| 2025-03-31 | 8.54M shares 10-Q · filed 2025-04-30 |
| 2024-12-31 | 6.44M shares 10-K · filed 2025-03-24 |
| 2024-09-30 | 6.29M shares 10-Q · filed 2024-10-30 |
| 2024-06-30 | 6.20M shares 10-Q · filed 2024-08-08 |
| 2024-03-31 | 5.85M shares 10-Q · filed 2024-05-09 |
| 2023-12-31 | 4.27M shares 10-K · filed 2024-03-14 |
| 2023-09-30 | 4.49M shares 10-Q · filed 2023-11-14 |
| 2023-06-30 | 4.48M shares 10-Q · filed 2023-08-10 |
| 2023-03-31 | 4.33M shares 10-Q · filed 2023-05-15 |
| 2022-12-31 | 3.07M shares 10-K · filed 2023-03-14 |
| 2022-09-30 | 3.14M shares 10-Q · filed 2022-11-10 |
| 2022-06-30 | 3.13M shares 10-Q · filed 2022-08-11 |
| 2022-03-31 | 3.08M shares 10-Q · filed 2022-05-12 |
| 2021-12-31 | 2.52M shares 10-K · filed 2022-03-25 |
| 2021-09-30 | 2.55M shares 10-Q · filed 2021-11-12 |
| 2021-06-30 | 2.55M shares 10-Q · filed 2021-08-12 |
| 2021-03-31 | 2.40M shares 10-Q · filed 2021-05-10 |
| 2020-12-31 | 2.01M shares 10-K · filed 2021-03-04 |
| 2020-09-30 | 1.95M shares 10-Q · filed 2020-11-12 |
| 2020-06-30 | 720.07K shares 10-Q · filed 2020-08-14 |
| 2016-12-31 | 3.08M shares 10-K · filed 2017-03-10 |
| 2015-12-31 | 2.56M shares 10-K · filed 2016-03-15 |
| 2014-12-31 | 2.01M shares 10-K · filed 2015-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |